The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of the cyclin dependent kinase 9 (CDK9) inhibitor FIT039 for cervical intraepithelial neoplasia (CIN) 1 or 2 in a phase I/II trial.
 
Junzo Hamanishi
Speakers' Bureau - MSD
Research Funding - AstraZeneca (Inst); Dainippon Sumitomo Pharma (Inst); Kinopharma (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Eriko Sumi
No Relationships to Disclose
 
Taito Miyamoto
No Relationships to Disclose
 
Ryuji Uozumi
No Relationships to Disclose
 
Koji Yamanoi
No Relationships to Disclose
 
Harue Tada
No Relationships to Disclose
 
Yoko Amino
Employment - Ono Pharmaceutical (I)
 
Yu Hidaka
No Relationships to Disclose
 
Masayo Ukita
No Relationships to Disclose
 
Ken Yamaguchi
No Relationships to Disclose
 
Ryuta Asada
No Relationships to Disclose
 
Masahiko Ajiro
No Relationships to Disclose
 
Teruo Sawada
Employment - BTB Drug Development Research Center
Leadership - BTB Drug Development Research Center
Stock and Other Ownership Interests - BTB Drug Development Research Center
Travel, Accommodations, Expenses - BTB Drug Development Research Center
 
Masatoshi Hagiwara
Leadership - BTB Drug Development Research Center
Stock and Other Ownership Interests - BTB Drug Development Research Center; HiLung; KinoPharma
Consulting or Advisory Role - KinoPharma
Speakers' Bureau - Nippon Boehringer Ingelheim
Research Funding - BTB Drug Development Research Center
Patents, Royalties, Other Intellectual Property - BTB Drug Development Research Center
 
Masaki Mandai
No Relationships to Disclose